These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37364592)

  • 21. [The use of tolvaptan in a case of severe hyponatriemia in SIADH during meningitis].
    Rollino C; Balbiano R; Caramello P; Roccatello D
    G Ital Nefrol; 2013; 30(6):. PubMed ID: 24402662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of long-term tolvaptan treatment in a patient with SCLC and SIADH.
    Bordi P; Tiseo M; Buti S; Regolisti G; Ardizzoni A
    Tumori; 2015 Apr; 101(2):e51-3. PubMed ID: 25702667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study.
    Estilo A; McCormick L; Rahman M
    Adv Ther; 2021 Dec; 38(12):5721-5736. PubMed ID: 34693505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolvaptan is successful in treating inappropriate antidiuretic hormone secretion in infants.
    Marx-Berger D; Milford DV; Bandhakavi M; Van't Hoff W; Kleta R; Dattani M; Bockenhauer D
    Acta Paediatr; 2016 Jul; 105(7):e334-7. PubMed ID: 27028950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficiency of Single Dose of Tolvaptan Treatment During the Triphasic Episode After Surgery for Craniopharyngioma.
    Gürbüz F; Taştan M; Turan İ; Yüksel B
    J Clin Res Pediatr Endocrinol; 2019 May; 11(2):202-206. PubMed ID: 30257818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolvaptan Treatment in Children with Chronic Hyponatremia due to Inappropriate Antidiuretic Hormone Secretion: A Report of Three Cases.
    Tuli G; Tessaris D; Einaudi S; De Sanctis L; Matarazzo P
    J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):288-292. PubMed ID: 28515029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Open-label, multicenter, dose-titration study to determine the efficacy and safety of tolvaptan in Japanese patients with hyponatremia secondary to syndrome of inappropriate secretion of antidiuretic hormone.
    Arima H; Goto K; Motozawa T; Mouri M; Watanabe R; Hirano T; Ishikawa SE
    Endocr J; 2021 Jan; 68(1):17-29. PubMed ID: 32863282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolvaptan treatment in hyponatremia due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): effects on survival in patients with cancer.
    Bilgetekin I; Erturk I; Basal FB; Karacin C; Karadurmus N; Oksuzoglu B; Demirci U
    Int Urol Nephrol; 2021 Feb; 53(2):301-307. PubMed ID: 32869173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-patient Tolvaptan use in SIADH: care audit, therapy observation and outcome analysis.
    Humayun MA; Cranston IC
    BMC Endocr Disord; 2017 Nov; 17(1):69. PubMed ID: 29110656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan.
    Petereit C; Zaba O; Teber I; Lüders H; Grohé C
    BMC Pulm Med; 2013 Aug; 13():55. PubMed ID: 23987478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of costs associated with tolvaptan-mediated hospital length of stay reduction among US patients with the syndrome of inappropriate antidiuretic hormone secretion, based on SALT-1 and SALT-2 trials.
    Dasta JF; Chiong JR; Christian R; Lin J
    Hosp Pract (1995); 2012 Feb; 40(1):7-14. PubMed ID: 22406878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amiodarone-Induced Hyponatremia Masked by Tolvaptan in a Patient with an Implantable Left Ventricular Assist Device.
    Nakamura M; Sunagawa O; Kugai T; Kinugawa K
    Int Heart J; 2017 Dec; 58(6):1004-1007. PubMed ID: 29151494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term low-dose tolvaptan efficacy and safety in SIADH.
    Bondanelli M; Aliberti L; Gagliardi I; Ambrosio MR; Zatelli MC
    Endocrine; 2023 Nov; 82(2):390-398. PubMed ID: 37507553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion.
    Tzoulis P; Waung JA; Bagkeris E; Carr H; Khoo B; Cohen M; Bouloux PM
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):620-6. PubMed ID: 26385871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose tolvaptan PK/PD: comparison of patients with hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion to healthy adults.
    Shoaf SE; Bricmont P; Dandurand A
    Eur J Clin Pharmacol; 2017 Nov; 73(11):1399-1408. PubMed ID: 28803333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syndrome of inappropriate secretion of antidiuretic hormone in traumatic brain injury: when tolvaptan becomes a life saving drug.
    Graziani G; Cucchiari D; Aroldi A; Angelini C; Gaetani P; Selmi C
    J Neurol Neurosurg Psychiatry; 2012 May; 83(5):510-2. PubMed ID: 22323742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SIADH with Severe Hyponatremia in an Elderly Man with Herpes Zoster Infection: A Causal or Casual Association?
    Foppiani L
    Intern Med; 2018 Dec; 57(23):3393-3398. PubMed ID: 29984775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolvaptan corrects hyponatremia and relieves the burden of fluid/dietary restriction and hospitalization in hyponatremic patients with terminal lung cancer: a report of two cases.
    Kai K; Tominaga N; Koitabashi K; Ichikawa D; Shibagaki Y
    CEN Case Rep; 2019 May; 8(2):112-118. PubMed ID: 30637666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asymptomatic meningitis diagnosed by positron emission tomography in a patient with syndrome of inappropriate antidiuretic hormone secretion: a case report.
    Hasebe M; Shirakawa J; Miyashita D; Kunishita R; Kyohara M; Okuyama T; Togashi Y; Terauchi Y
    J Med Case Rep; 2021 Jul; 15(1):390. PubMed ID: 34289912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case report: Twice-daily tolvaptan dosing regimen in a challenging case of hyponatremia due to SIAD.
    Arecco A; Demontis D; Della Sala L; Musso N; Gay S; Boschetti M; Ferone D; Gatto F
    Front Endocrinol (Lausanne); 2023; 14():1309657. PubMed ID: 38288467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.